The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Cleveland Biolabs Inc

Nasdaq: CBLI
Last

(U.S.) $2.09

Today's change0.00 0.00%
Updated August 25 3:01 PM -4GMT. Delayed by at least 15 minutes.
 

Cleveland Biolabs Inc

Nasdaq: CBLI
Last

(U.S.) $2.09

Today's change0.00 0.00%
Updated August 25 3:01 PM -4GMT. Delayed by at least 15 minutes.

Cleveland Biolabs Inc closed at (U.S.)$2.09.

Over the last five days, shares have lost 3.83% and are down 40.04% for the last year to date. This security has underperformed the S&P 500 by 59.30% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $2.09
  • High--
  • Low--
  • Bid / Ask(U.S.) $1.32 / (U.S.) $2.65
  • YTD % change-40.04%
  • Volume0
  • Average volume (10-day)25,746
  • Average volume (1-month)19,426
  • Average volume (3-month)18,199
  • 52-week range(U.S.) $1.92 to (U.S.) $5.29
  • Beta0.88
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.67
Updated August 25 3:01 PM -4GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue1111
Total other revenue--------
Total revenue1111
Gross profit--------
Total cost of revenue--------
Total operating expense2333
Selling / general / administrative1111
Research & development1222
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)----0--
Other operating expenses, total--------
Operating income-1-2-2-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-1-2-3
Income after tax-2-1-2-3
Income tax, total--------
Net income-2-1-1-3
Total adjustments to net income--------
Net income before extra. items-2-1-1-3
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2-1-1-3
Inc. avail. to common incl. extra. items-2-1-1-3
Diluted net income-2-1-1-3
Dilution adjustment--------
Diluted weighted average shares11111110
Diluted EPS excluding extraordinary itemsvalue per share-0.17-0.06-0.13-0.31
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.17-0.06-0.13-0.31